News

Ferring Pharmaceuticals, a biopharmaceutical company, has launched a Phase IIIb clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone receptor antagonist approved by the FDA for

The Netherlands-based biotechnology company Pharming Group has reported that its wholly owned subsidiary DNage has received a notice from the FDA that its product Prodarsan has obtained an

Peregrine Pharmaceuticals, a biopharmaceutical company, has reported that updated preliminary data from its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer

Visiogen, a developer of products for cataract and refractive patients, has raised $40 million from new and current investors to support the global commercialization of the Synchrony dual

US-based healthcare company PerkinElmer and Cerep, a provider of drug candidate screening and profiling technologies, have expanded their kinase assay offering. Close to 200 new kinase assays validated

IOPtima, a subsidiary of Bio-Light, the developer of a laser-based surgical device for reducing intra ocular pressure for the treatment of glaucoma, has successfully completed and analyzed the

Medtronic, a medical technology company, has started Thrive1, the company’s US post-market clinical study of its Talent thoracic stent graft for the endovascular repair of thoracic aortic aneurysms.

Norway-based biotechnology company Pronova BioPharma has reported that Pronova BioPharma Norge AS has filed a lawsuit against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Ltd in the US

OncoPredictor combines MDS Pharma Services OncoPanel with Compendia Bioscience’s Oncomine for a solution that will provide guidance on patient groups most likely to respond to a new cancer